Published September 2018 | Version v1
Journal article

Laser-assisted cell removing (LACR) technology contributes to the purification process of the undifferentiated cell fraction during pluripotent stem cell culture

  • 1. Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine (Japan)
  • 2. Division of Cell Biology for Regenerative Medicine, Institute of Advanced Clinical Medicine, Kindai University Faculty of Medicine, Osaka (Japan)
  • 3. Sinfonia Technology Co. Ltd. (Japan)
  • 4. Kindai University Life Science Research Institute, Kindai University (Japan)
  • 5. Laboratory of Embryonic Stem Cell Research, Institute for Frontier Life and Medical Sciences, Kyoto University (Japan)

Description

Highlights: • Purification of undifferentiated cells is a critical step in stem cell culture. • We developed an automated laser-assisted cell removing technology. • This system successfully removed contaminated/differentiated cells in human iPS cell culture. Purification of undifferentiated cells by removing differentiated parts is an essential step in pluripotent stem cell culture. This process has been traditionally performed manually using a fine glass capillary or plastic tip under a microscope, or by culturing in a selective medium supplemented with anti-differentiation inhibitors. However, there are several inevitable problems associated with these methods, such as contamination or biological side-effects. Here, we developed a laser-assisted cell removing (LACR) technology that enables precise, fast, and contact-less cell removal. Using LACR combined with computational image recognition/identification-discriminating technology, we achieved automatic cell purification (A-LACR). Practicability of A-LACR was evaluated by two demonstrations: selective removal of trophoblast stem (TS) cells from human iPS and TS cell co-cultures, and purification of undifferentiated iPS cells by targeting differentiated cells that spontaneously developed. Our results suggested that LACR technology is a novel approach for stem cell processing in regenerative medicine.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2018.08.101

Additional details

Identifiers

DOI
10.1016/j.bbrc.2018.08.101;
PII
S0006291X18317856;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
503
Journal Issue
4
Journal Page Range
p. 3114-3120
ISSN
0006-291X
CODEN
BBRCA9

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
53051491
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
CAPILLARIES; CELL CULTURES; DRUGS; SIDE EFFECTS; STEM CELLS
Descriptors DEC
ANIMAL CELLS; BLOOD VESSELS; BODY; CARDIOVASCULAR SYSTEM; ORGANS; SOMATIC CELLS

Optional Information

Copyright
Copyright (c) 2018 The Authors. Published by Elsevier Inc.